Prognostic Biochemical Markers in Traumatic Brain Injury: Which One is The Best?

Juwita Juwita Juwita, Hidayaturrahmi Hidayaturrahmi Hidayaturrahmi, Muhammad Ansari Adista, Khairunnisa Khairunnisa Ichwan

Abstract


Traumatic brain injury is significant cause of disability and mortality; most of the patient are young and productive. The Glasgow Coma Scale (GCS) is a common tool for classifying the injury, while imaging is used to diagnose. However, those modalities have limitations, which is mild to moderate brain injury due to the brain parenchymal changes cannot be found on imaging. Currently, several marker proteins (biochemical markers) of body fluids such as cerebrospinal fluid, blood or urine have been studied and are specific enough and easily accessible for classification and predict prognosis of traumatic brain injury. Biochemical markers which are widely used, considered effective and accurate for diagnosis and prognosis brain injury are S100β, GFAP, neuron-specific enolase (NSE), and tau. This study will describe and compare the characteristics and role of each of these marker proteins.


Keywords


biochemical marker, glasgow goma scale, imaging, prognostic, traumatic brain injury

References


Syafrita Y and Fitri N. Analysis of Neuron Specific Enolase Serum Levels in Traumatic Brain Injury. Biosci Med J Biomed Transl Res. 2021;5(4):1218–22.

Mulyono D. Perbedaan Nationale Early Warning Score dan Glasgow Coma Scale dalam Memprediksi Outcome Pasien Trauma Kepala di Instalasi Gawat Darurat. J Akad Keperawatan Husada Karya Jaya. 2021;7(1):15–23.

Mustarhfiroh, Saragih SGR, Natalia D. Hubungan antara Glasgow Coma Scale dan Tingkat Mortalitas pada Pasien Cedera Kepala dengan Lesi Perdarahan Subarachnoid. J Kesehat Khatulistiwa. 2018;4(1):430–9.

Rogan A, Patel V, Birdling J, Lockett J, Simmonds H, McQuade D, et al. Acute traumatic brain injury and the use of head computed tomography scans in the emergency department. Trauma [Internet]. 2022;24(4):327–36. Available from: https://doi.org/10.1177/14604086211023646

Borumand MR, Babaloii F, Mirmotahari SA, Maghsoudi AS, Torabi R, Mojtahedzadeh M, et al. Recent trends and innovations in biosensors development for biomarkers towards monitoring traumatic brain injury. Biosens Bioelectron X [Internet]. 2022;12:e100247–e100247. Available from: http://dx.doi.org/10.1016/j.biosx.2022.100247

Anindhita T, Harris S, Wiratman W. Buku Ajar Neurologi. Edisi Kedua. Anindhita T, Harris S, Wiratman W, editors. Departemen Neurologi FK UI; 2022.

Fert-Bober J, Pandey R, Dardov VJ, Van Meter TE, Edmonds DJ, Van Eyk JE. Chapter 6 - Traumatic brain injury: glial fibrillary acidic protein posttranslational modification. In: Wu AHB, Peacock WFBTB for TBI, editors. Academic Press; 2020. p. 77–91. Available from: https://www.sciencedirect.com/science/article/pii/B9780128163467000063

Blais Lécuyer J, Mercier É, Tardif PA, Archambault PM, Chauny JM, Berthelot S, et al. S100B protein level for the detection of clinically significant intracranial haemorrhage in patients with mild traumatic brain injury: a subanalysis of a prospective cohort study. Emerg Med J. 2021 Apr;38(4):285–9.

Chen W, Wang G, Yao C, Zhu Z, Chen R, Su W, et al. The ratio of serum neuron-specific enolase level to admission glasgow coma scale score is associated with diffuse axonal injury in patients with moderate to severe traumatic brain injury. Front Neurol. 2022;13:887818.

Allouchery G, Moustafa F, Roubin J, Pereira B, Schmidt J, Raconnat J, et al. Clinical validation of S100B in the management of a mild traumatic brain injury: issues from an interventional cohort of 1449 adult patients. Clin Chem Lab Med. 2018 Oct;56(11):1897–904.

Ghaith HS, Nawar AA, Gabra MD, Abdelrahman ME, Nafady MH, Bahbah EI, et al. A Literature Review of Traumatic Brain Injury Biomarkers. Mol Neurobiol. 2022 Jul;59(7):4141–58.

Dzierzęcki S, Ząbek M, Zaczyński A, Tomasiuk R. Prognostic properties of the association between the S-100B protein levels and the mean cerebral blood flow velocity in patients diagnosed with severe traumatic brain injury. Biomed reports. 2022 Jul;17(1):58.

Faisal M, Vedin T, Edelhamre M, Forberg JL. Diagnostic performance of biomarker S100B and guideline adherence in routine care of mild head trauma. Scand J Trauma Resusc Emerg Med. 2023 Jan;31(1):3.

Huebschmann NA, Luoto TM, Karr JE, Berghem K, Blennow K, Zetterberg H, et al. Comparing Glial Fibrillary Acidic Protein (GFAP) in Serum and Plasma Following Mild Traumatic Brain Injury in Older Adults. Front Neurol. 2020;11:1054.

Hier DB, Obafemi-Ajayi T, Thimgan MS, Olbricht GR, Azizi S, Allen B, et al. Blood biomarkers for mild traumatic brain injury: a selective review of unresolved issues. Biomark Res. 2021;9(1):1–17.

Czeiter E, Amrein K, Gravesteijn BY, Lecky F, Menon DK, Mondello S, et al. Blood biomarkers on admission in acute traumatic brain injury: Relations to severity, CT findings and care path in the CENTER-TBI study. EBioMedicine. 2020 Jun;56:102785.

Mercier E, Tardif PA, Cameron PA, Émond M, Moore L, Mitra B, et al. Prognostic value of neuron-specific enolase (NSE) for prediction of post-concussion symptoms following a mild traumatic brain injury: a systematic review. Brain Inj. 2018;32(1):29–40.

Bezek S, Biberthaler P, Martinez-Espina I, Bogner-Flatz V. Pathophysiology and clinical implementation of traumatic brain injury biomarkers: Neuron-specific enolase [Internet]. Biomarkers for Traumatic Brain Injury. INC; 2020. 169–182 p. Available from: http://dx.doi.org/10.1016/B978-0-12-816346-7.00011-7

Congdon EE, Sigurdsson EM. Tau-targeting therapies for Alzheimer disease. Nat Rev Neurol. 2018 Jul;14(7):399–415.

Flavin WP, Hosseini H, Ruberti JW, Kavehpour HP, Giza CC, Prins ML. Traumatic brain injury and the pathways to cerebral tau accumulation. Front Neurol. 2023;14(August):1–17.

Edwards G 3rd, Zhao J, Dash PK, Soto C, Moreno-Gonzalez I. Traumatic Brain Injury Induces Tau Aggregation and Spreading. J Neurotrauma. 2020 Jan;37(1):80–92.




DOI: https://doi.org/10.30596/jih.v5i1.17534

Refbacks

  • There are currently no refbacks.


 

Fakultas Kedokteran

Universitas Muhammadiyah Sumatera Utara
Jln.Gedung Arca No. 53 Medan 20217
Telp/HP/Whatsapp: +62 8112570085, +62 857-6248-0974
Website : http://jurnal.umsu.ac.id/index.php/JIH/index
Email : implementahusada@umsu.ac.id